July 28 (Reuters) - LeMaitre Vascular Inc LMAT.O :
* LEMAITRE Q2 2022 FINANCIAL RESULTS
* LEMAITRE VASCULAR INC - QTRLY SALES OF $42.1MM, +4% (+8%
ORGANIC) VERSUS Q2 2021
* LEMAITRE VASCULAR INC - QTRLY EARNINGS PER DILUTED SHARE
REPORTED $0.16
* LEMAITRE VASCULAR INC - QTRLY EARNINGS PER DILUTED SHARE
EX.
SPECIAL CHARGE $0.29
* LEMAITRE VASCULAR INC SEES Q3 SALES $39.0MM - $41.0MM
(MID:
$40.0MM, +4%, +10% ORG.)
* LEMAITRE VASCULAR INC SEES Q3 EPS $0.24 - $0.29 (MID:
$0.27,
-10%)
* LEMAITRE VASCULAR INC SEES FY SALES $162.7MM - $165.3MM
(MID:$164.0MM, +6%, +10% ORG.)
* LEMAITRE VASCULAR INC SEES FY EPS $0.99 - $1.05 (MID:
$1.02,
-19%)
* LEMAITRE VASCULAR INC SEES FY EPS EX-SPEC. CHARGE $1.14 -
$1.19
(MID: $1.17, -7%)
Source text for Eikon: ID:nGNX66h6pY
Further company coverage: LMAT.O
((Reuters.Briefs@thomsonreuters.com;))